GlaxoSmithKline Blog | Talkmarkets

Latest Posts

Sanofi, GSK Start Final Testing Phase Of COVID-19 Vaccine

Article By: Benzinga

Thursday, May 27, 2021 9:00 AM EDT

Sanofi SA and GlaxoSmithKline plc have launched a Phase 3 trial for its recombinant COVID-19 vaccine candidate, which they hope to get approved by the end of 2021.

In this article: SNY, GSK

Read

GlaxoSmithKline Q1 Profit, Sales Decline As COVID-19 Vaccination Delay Other Treatments; Backs 2021 Outlook

Article By: Benzinga

Wednesday, April 28, 2021 10:44 AM EDT

GlaxoSmithKline Plc Q1 revenue fell 18% in the first quarter, as the COVID-19 vaccination program delayed sales of its Shingrix shot for shingles.

In this article: GSK

Read

Vir, GSK Covid Trial Stopped After VIR-7831 Shows 85% Reduction In Deaths

Article By: The Fly

Thursday, March 11, 2021 7:44 AM EDT

Vir and GSK plan to submit an Emergency Use Authorization application to the Food and Drug Administration and for authorizations in other countries.

In this article: GSK, VIR

Read

Speculative Appetite Is Sinking In Biotech With Latest Rotation

Article By: Rod Raynovich

Thursday, March 4, 2021 5:38 AM EDT

As we have noted in recent posts there is less appetite for speculative trades in biotech. Some of it is related to concerns in the general market about rising Ten Year Treasury yields and supported by weak technicals.

In this article: GSK, MRK, PFE, IBB, XBI, ARKG

Read

CureVac, GSK In Pact To Jointly Develop MRNA Vaccines For COVID-19

Article By: The Fly

Wednesday, February 3, 2021 8:28 AM EDT

GlaxoSmithKline and CureVac announced a new EUR 150M collaboration to jointly develop next-generation mRNA vaccines for COVID-19 "with the potential for a multi-valent approach to address multiple emerging variants in one vaccine."

In this article: GSK, CVAC

Read

All Posts